Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Current status and progress of prognostic evaluation in marginal zone lymphoma].

Zhonghua yi xue za zhi - 23 Jun 2026

Liu Y N, Fang J, Zhou F L, Mei H

Abstract excerpt

Marginal zone lymphoma (MZL) is an indolent B-cell non-Hodgkin lymphoma with marked heterogeneity. Currently, histological subtype, clinical stage, biochemical parameters, and clinical scoring systems represented by the MZL-international prognostic index (MZL-IPI) remain the principal basis for risk stratification; however, their differentiation power is limited, particularly for intermediate-risk groups, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CXCR4 gene
Share to NOTCH2 gene
Share to TNFAIP3 gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to TP53 gene

Share to Lymphoma, B-Cell, Marginal Zone

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 42297592
DOI: 10.3760/cma.j.cn112137-20260113-00150

Genes

CXCR4
KLF2
TP53
NOTCH2
TNFAIP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Current status and progress of prognostic evaluation in marginal zone lymphoma].PMID 42297592Read ↗

The biology of marginal zone lymphoma subtypes: challenge and relevance of classification.Semantic proximity Read ↗

Nodal marginal zone lymphoma.Semantic proximity Read ↗

Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.Semantic proximity Read ↗

Marginal zone lymphomasSemantic proximity Read ↗

The genetic landscape of histologically transformed marginal zone lymphomasSemantic proximity Read ↗

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targetsSemantic proximity Read ↗

Optimizing therapy for nodal marginal zone lymphomaSemantic proximity Read ↗

New Insights into the Biology and Diagnosis of Splenic Marginal Zone LymphomasSemantic proximity Read ↗

Nodal Marginal Zone Lymphoma: A Heterogeneous TumorSemantic proximity Read ↗

Mediastinal Gray Zone Lymphomas: Diagnostic Challenges, Clinicopathologic Overlap, and Emerging Management StrategiesSemantic proximity Read ↗

Mantle cell lymphoma pathology update in the 2016 WHO classificationSemantic proximity Read ↗

[Clinicopathological features and BRAF V600E and MYD88 L265P mutation status of nodal marginal zone lymphoma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.